Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Philippe Sagnier"'
Publikováno v:
Journal of Clinical Oncology. 25:5087-5093
Assessing patient-reported outcomes (PROs) in clinical trials is of interest to clinicians, patients, regulators, and industry. The use and impact of PROs is a growing area of methodologic research, particularly as they relate to tumor types, biomark
Publikováno v:
Quality of Life Research. 12:117-132
The purpose of the study is to compare a generic and a specific quality of life (QoL) instrument in the assessment of QoL in chronic bronchitis. Data from 320 patients were collected at acute exacerbation of chronic bronchitis (AECB), and from 230 pa
Autor:
Patrick Marquis, Alexia Marrel, Isabelle Duprat-Lomon, Sara Schroter, Donna L. Lamping, Pierre-Philippe Sagnier
Publikováno v:
Chest. 122:920-929
Study objectives To develop and validate a patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia (CAP). Design A psychometric study within an international, prospective, randomized, double-blind study. The C
Autor:
Helen Doll, I Duprat-Lomon, Pierre-Philippe Sagnier, P Grey-Amante, J Lorenz, Reinhard Rychlik, T. Pfeil, Thate-Waschke Im
Publikováno v:
Respiratory Medicine. 96(1):39-51
This study reports on data from a study conducted in the Federal Republic of Germany examining the quality of life (QoL) of patients with chronic bronchitis (CB) and its acute exacerbations (AECB). Data from 320 patients were collected at AECB and su
Autor:
Thomas Weihrauch, Andrew Freeman, Florian Bieber, Karl W. Lauterbach, Michael Zuehlsdorf, Gerd Glaeske, Celia Brazell, Adrian Towse, Gerhard Waltl, Werner Kroll, Mike Wallace, Pierre-Philippe Sagnier, Elizabeth Foot
Publikováno v:
International Journal of Pharmaceutical Medicine. 15:95-100
Health care and pharmacogenetics The main focus of the interaction between health care and pharmacogenetics is the individual patient who will benefit in several ways: Individualized differential diagnosis and differential therapy will result in more
Autor:
Elizabeth Foot, Florian Bieber, Werner Kroll, Pierre-Philippe Sagnier, Gerhard Waltl, Michael Zuehlsdorf, Celia Brazell, Andrew Freeman, Mike Wallace, Gerd Glaeske, Karl Lauterbach, Adrian Towse, Thomas Weihrauch
Publikováno v:
International Journal of Pharmaceutical Medicine. 15:95-100
Autor:
Claude Marmignon, Jean Perraud, Michel Lefebvre, Thierry Pot, Ajmal K. Mohamed, Serge Larigaldie, Daniel Pigache, Véronique Joly, Bruno Chanetz, Jean-Luc Vérant, Johan William, Philippe Sagnier, Reynald Bur
Publikováno v:
Aerospace Science and Technology. 4:347-361
This article deals with the research performed in the framework of the internal ONERA Hyperenthalpic Hypersonic Project. This project involved fifteen researchers specialised in different domains, which are the following: fundamental studies on shock
Autor:
Annabelle Shakespeare, Pierre-Philippe Sagnier, Richard Shikiar, David Wilkinson, Bruno Dubois, Ian G. McKeith, Jean-François Dartigues
Publikováno v:
Journal of the American Geriatrics Society. 48:268-274
OBJECTIVE: To assess the impact on burden reported by caregivers of patients with mild to moderate Alzheimer's disease (AD) who were treated with metrifonate during a randomized double blind clinical trial. DESIGN: Randomized clinical trial, with a 2
Autor:
Jean-Luc Vérant, Philippe Sagnier
Publikováno v:
AIAA Journal. 36:522-531
Experimental results obtained in the ONERA F4 hot-shot wind tunnel have been analyzed to address two important problems for this type of wind tunnel, i.e., the determination of reservoir conditions and the thermochemical nature of the nozzle flow. Nu
Autor:
Jeremy Chancellor, Debbie L. Becker, Rolf Kubin, Margaret Hux, I Duprat-Lomon, Pierre-Philippe Sagnier, Michael Drummond
Publikováno v:
Chest. 124(2)
Study objective To evaluate costs, clinical consequences, and cost-effectiveness from a German and French health-care system perspective of sequential IV/po moxifloxacin monotherapy compared to co-amoxiclav with or without clarithromycin (AMC ± CLA)